BRANFORD, Conn., Oct. 6, 2008 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (Nasdaq:CASM), a leader in noninvasive monitoring that is vital to patient care, today announced that it has been named to the Connecticut Technology Council's inaugural UHY LLP Tech Top 40 program, a celebration of the 40 fastest growing Software, IT, New Media, Advanced Manufacturing, Energy/Telecom/Green Tech and Life Sciences companies in Connecticut. Selection was based on the percentage revenue growth over four years from 2004-2007.
Andrew E. Kersey, CASMED's President and CEO, credits the Company's solid foundation, along with its new product innovations, with the company's 91 percent revenue growth from 2004 to 2007. Kersey stated, "CASMED has a strong base of business in the vital signs monitoring marketplace, showing steady growth year after year. This has helped support our development of new and innovative products, including our FORE-SIGHT(r) Absolute Cerebral Oximeter, which provides opportunity for significant growth in the future."
To qualify for the UHY LLP Tech Top 40, companies must have had operating revenues of at least $50,000 in 2004 and $3,000,000 in 2007, be headquartered in Connecticut, and own proprietary technology or proprietary intellectual property that contributes to a significant portion of the company's operating revenues; or devotes a significant portion of revenues to the research and development of technology.
About CASMED(r) -- Monitoring What's Vital
CAS Medical Systems, Inc. is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company's FORE-SIGHT Absolute Cerebral Oximeter is the only cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for neonates, infants, children and adults. This information helps avert brain damage or death during surgery and in critical care situations by allowing clinicians to identify patients with dangerously low levels of cerebral oxygen and intervene to reverse the condition.
The Company's product lines include the high-acuity monitoring capabilities of the FORE-SIGHT Cerebral Oximeter, the bedside patient monitoring line of vital signs and cardio-respiratory monitoring products, proprietary non-invasive blood pressure measurement technology, and supplies and service including blood pressure cuffs and products for neonatal intensive care. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates.
For further information regarding CAS Medical Systems, Inc., visit the Company's website at www.casmed.com.
The CAS Medical Systems, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4675
About UHY LLP
UHY LLP is a licensed independent CPA firm that performs attest services for UHY Advisors, Inc. UHY Advisors, Inc. provides tax and business consulting services through wholly owned subsidiary entities that operate under the name "UHY Advisors." UHY Advisors, Inc. and its subsidiary entities have more than 1300 professionals providing services from 23 offices across the United States. UHY Advisors, Inc. and its subsidiaries are not licensed CPA firms. UHY LLP and UHY Advisors, Inc. are independent members of UHY International. www.uhyllp-us.com.
About The Connecticut Technology Council, Inc.
The Connecticut Technology Council is the state's industry association for the technology sector. CTC's mission is to "connect people, ideas and opportunities to the global technology and innovation community." CTC provides members with business assistance and specialized programs, in addition to promoting and supporting public policies that position Connecticut to have a globally recognized "culture of innovation" that helps attract great ideas and entrepreneurs to, in turn, develop new jobs and wealth for the state. www.ct.org.
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future financial performance of the Company are subject to many factors including, but not limited to, the customer acceptance of the products in the market, the introduction of competitive products and product development, commercialization and technological difficulties, the impact of actions and events involving key customers and vendors, and other risks detailed in the Company's Form 10-K for the year ended December 31, 2007 and other subsequent Securities and Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will" and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information or otherwise.